These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 905179)

  • 41. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis].
    Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT
    Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heparin usage in chronic hemodialysis.
    Lewis LM
    Nephrol Nurse; 1981; 3(2):33, 47. PubMed ID: 6907680
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of acetate and bicarbonate hemodialysis on protein and lipid metabolism in patients with chronic kidney failure].
    Shostka GD; T'iagi S; Rumiantsev ASh; Kozlov VV; Smirnov AV; Kulikova AI
    Ter Arkh; 1990; 62(6):88-92. PubMed ID: 2218936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of respiratory tract functions in children with chronic renal failure treated with hemodialysis].
    Zajaczkowska M; Górnicka G; Kołłataj B; Pietraszek-Mamcarz J
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():15-7. PubMed ID: 11081335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hormonal and lipid changes in patients with chronic renal insufficiency in hemodialysis].
    Joven J; Espinel E; Munné J
    Med Clin (Barc); 1985 Sep; 85(9):388-9. PubMed ID: 4079582
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drug acetylation processes in patients with chronic renal failure treated by hemodialysis].
    Milejski P; Strychowski J; Orzechowska-Juzwenko K; Szewczyk Z; Klinger M; Kramarz S
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):686-8. PubMed ID: 1492037
    [No Abstract]   [Full Text] [Related]  

  • 47. [Liver function tests in patients with terminal renal failure treated conservatively and with repeated hemodialysis].
    Smoleński O; Caban M; Kutrzeba W
    Pol Tyg Lek; 1980 Feb; 35(8):273-5. PubMed ID: 7360704
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
    Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastrointestinal blood loss in patients undergoing maintenance dialysis.
    Wizemann V; Buddensiek P; de Boor J; Grebe S; Schütterle G
    Kidney Int Suppl; 1983 Dec; 16():S218-20. PubMed ID: 6588252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevention of thrombosis of the arteriovenous shunts used for hemodialysis].
    Mal'kov PS; Aliev RA
    Urol Nefrol (Mosk); 1974; (6):41-4. PubMed ID: 4446186
    [No Abstract]   [Full Text] [Related]  

  • 51. [Correction of blood rheological disorders in patients with chronic kidney failure using heparin and antiaggregants].
    Vorob'ev PA; Dvoretskiĭ LI; Aĭnabekova BA; Iaroslavtseva GN; Miagkov AV
    Ter Arkh; 1988; 60(5):73-6. PubMed ID: 3175933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
    Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
    ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Influence of experience on the success of the treatment of chronic kidney failure by continuous ambulatory peritoneal dialysis compared with hemodialysis at a center].
    Marichal JF; Cordier B; Hedelin G; Faller B; Brignon P
    Pathol Biol (Paris); 1990 Feb; 38(2):99-104. PubMed ID: 2314932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anti-influenza vaccination in patients with kidney failure treated by periodic hemodialysis and in renal transplant patients].
    Lagrange P; Cateigne G
    Bull Acad Natl Med; 1971 Nov; 155(30):767-70. PubMed ID: 4948397
    [No Abstract]   [Full Text] [Related]  

  • 55. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 57. [Lipid changes during hemodialysis].
    Cerezo Morales S; Abellan Pérez M; Vilchez Joya R; Hervas Sánchez J; Montes Puerta A; Peña Yáñez A
    Rev Clin Esp; 1978 Jan; 148(2):181-5. PubMed ID: 635271
    [No Abstract]   [Full Text] [Related]  

  • 58. [Changes in platelet function in subjects with chronic renal insufficiency treated with periodical hemodialysis].
    Ferri GM; Taccone-Gallucci M; Bongiovanni P; Mazzarella V; Casciani CU
    Minerva Nefrol; 1981; 28(4):471-5. PubMed ID: 7339516
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of hemodialysis on the course of blood sugar curve in patients with chronic renal failure].
    Poplawski A; Oleńska T
    Pol Tyg Lek; 1974 Oct; 29(42):1781-3. PubMed ID: 4419200
    [No Abstract]   [Full Text] [Related]  

  • 60. [Electrocardiographic changes in patients with chronic kidney failure treated by periodic hemodialysis].
    Krivoshiev S; Kiriakov Z; Antonov S
    Vutr Boles; 1987; 26(5):64-7. PubMed ID: 3433731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.